Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Jun / Bitesized Breakthroughs
Oncology Digital and computational pathology Genetics and epigenetics Omics Oncology Molecular Pathology

Bitesized Breakthroughs

The latest research in pathology and laboratory medicine

By Liv Gaskill 06/10/2021 Quick Read (pre 2022) 1 min read

Share

Biopsies Be Gone
Researchers have developed a new urine test that measures the levels of both protein marker EN2 and 10 genes associated with prostate cancer risk (1). The test can predict whether a patient has prostate cancer and how aggressive the disease is – reducing the need for invasive biopsies.

Looking at Ligands
Artificial intelligence has been used to investigate whether amphiregulin and epiregulin immunohistochemistry (IHC) could predict treatment response in metastatic colorectal cancer patients (2). The model found that high ligand expression was associated with better response to anti-EGFR treatment, showing IHC’s potential in routine practice.

Exposing Vulnerabilities
Hippocampal gene expression changes and associated hippocampal vulnerability have been examined to investigate disease-relevant gene expression in the brain (3). SERPINA5, RYBP, SLC38A2, FEM1B, and PYDC1 were found to be associated with Alzheimer’s disease neuropathology and SERPINA5 was further associated with tau expression – a key characteristic of the disease.

35 Years On
Two new studies have investigated radiation-induced genetic changes caused by the Chernobyl disaster. The first found no evidence of de novo germline mutations in children whose parents were exposed to radiation – suggesting minimal transgenerational genetic effects (4). However, the second identified increased radiation-associated damage in papillary thyroid carcinoma patients who were exposed at a younger age (5).

Novel Nanodevice
Researchers have developed a design pipeline for DNA assemblies that allows users to build structures either top-down or bottom-up, enabling rapid construction of complex multicomponent structures while maintaining control over geometrical, mechanical, and dynamical components (6).

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. SP Connell et al., Cancers (Basel), 13, 2102 (2021). PMID: 33925381.
  2. CJM Williams et al., Clin Cancer Res, [Online ahead of print] (2021). PMID: 33888518.
  3. AM Crist et al., Nat Commun, 12, 2311 (2021). PMID: 33875655.
  4. M Yeager et al., Science, 372, 725 (2021). PMID: 33888597.
  5. LM Morton et al., Science, 372, eabg2538 (2021). PMID: 33888599.
  6. CM Huang et al., Nat Mater, [Online ahead of print] (2021). PMID: 33875848.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.